Cargando…

The Role of Apolipoprotein E in Guillain-Barré Syndrome and Experimental Autoimmune Neuritis

Apolipoprotein E (apoE) is a 34.2 kDa glycosylated protein characterized by its wide tissue distribution and multiple functions. ApoE has been widely studied in lipid metabolism, cardiocerebrovascular diseases, and neurodegenerative diseases like Alzheimer's disease and mild cognitive impairmen...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Hong-liang, Wu, Jiang, Zhu, Jie
Formato:	Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2010
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2825561/ https://www.ncbi.nlm.nih.gov/pubmed/20182542 http://dx.doi.org/10.1155/2010/357412

Ejemplares similares

Beneficial or Harmful Role of Macrophages in Guillain-Barré Syndrome and Experimental Autoimmune Neuritis
por: Shen, Donghui, et al.
Publicado: (2018)

Sex differences in Guillain Barré syndrome, chronic inflammatory demyelinating polyradiculoneuropathy and experimental autoimmune neuritis
por: McCombe, Pamela A., et al.
Publicado: (2022)

The effects of vasoactive intestinal peptide in the rat model of experimental autoimmune neuritis and the implications for treatment of acute inflammatory demyelinating polyradiculoneuropathy or Guillain–Barré syndrome
por: Jiao, Hong, et al.
Publicado: (2018)

CCR2 Gene Deletion and Pharmacologic Blockade Ameliorate a Severe Murine Experimental Autoimmune Neuritis Model of Guillain-Barré Syndrome
por: Yuan, Furong, et al.
Publicado: (2014)

The Immune-Modulatory Role of Apolipoprotein E with Emphasis on Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis
por: Zhang, Hong-Liang, et al.
Publicado: (2010)

Human Rabies with Initial Manifestations that Mimic Acute Brachial Neuritis and Guillain-Barré Syndrome
por: Mader, Edward C., et al.
Publicado: (2012)

Guillain–Barré syndrome
por: Mirian, Ario, et al.
Publicado: (2021)

Guillain-Barre syndrome: An autoimmune disorder post-COVID-19 vaccination?
por: Khan, Zafran, et al.
Publicado: (2022)

Risk factors for the severity of Guillain-Barré syndrome and predictors of short-term prognosis of severe Guillain-Barré syndrome
por: Wen, Puyuan, et al.
Publicado: (2021)

Intensive Care and Treatment of Severe Guillain–Barré Syndrome
por: Shang, Pei, et al.
Publicado: (2021)

Optic Neuritis, Miller Fisher Syndrome, and Guillain Barre Syndrome Overlap Secondary to Scrub Typhus in a North Indian Girl
por: Nagarajan, Balamurugan, et al.
Publicado: (2022)

Hyperreflexic Guillain-Barré syndrome
por: Baheti, Neeraj N., et al.
Publicado: (2010)

An Update in Guillain-Barré Syndrome
por: Winer, J. B.
Publicado: (2014)

Guillain–Barré syndrome mimics
por: Tham, Sai Leong, et al.
Publicado: (2018)

Syndrome de Guillain–Barré
por: Mirian, Ario, et al.
Publicado: (2021)

Protective Role of Limitrin in Experimental Autoimmune Optic Neuritis
por: Chun, Bo Young, et al.
Publicado: (2021)

Fasting Glucose Levels Correlate with Disease Severity of Guillain-Barré Syndrome
por: Wang, Ying, et al.
Publicado: (2015)

Siponimod ameliorates experimental autoimmune neuritis
por: Uchi, Takafumi, et al.
Publicado: (2023)

Hepatitis E virus as a trigger for Guillain-Barré syndrome
por: Fritz-Weltin, Miriam, et al.
Publicado: (2021)

Biomarkers of Guillain-Barré Syndrome: Some Recent Progress, More Still to Be Explored
por: Wang, Ying, et al.
Publicado: (2015)

Vision Loss in Guillain-Barre Syndrome: Is it a Complication of Guillain-Barre Syndrome or Just a Coincidence?
por: Ramakrishnan, Sri, et al.
Publicado: (2016)

SAT-683 A Case of Autoimmune Polyglandular Syndrome Type 2 and Guillain-Barré Syndrome
por: Cutler, Jason, et al.
Publicado: (2020)

Guillain-Barre syndrome and mood disorders
por: Neroutsos, Evangelos, et al.
Publicado: (2010)

Treatment guidelines for Guillain–Barré Syndrome
por: Meena, A. K., et al.
Publicado: (2011)

Brucellosis, Presenting with Guillain-Barré Syndrome
por: Babamahmoodi, Farhang, et al.
Publicado: (2011)

Syringomyelia Coexisting With Guillain-Barre Syndrome
por: Kim, Hee-Sang, et al.
Publicado: (2013)

Fulminant Guillain-Barré Syndrome with Myocarditis
por: Mishra, Ajay, et al.
Publicado: (2014)

Prognosis of Guillain-Barré Syndrome in Children
por: SALEHIOMRAN, Mohammad Reza, et al.
Publicado: (2016)

Outbreak of Guillain-Barre syndrome in Peru
por: Díaz-Soto, S., et al.
Publicado: (2019)

Guillain-Barré syndrome in times of pandemics
por: Leonhard, Sonja E, et al.
Publicado: (2020)

COVID-19 and Guillain-Barré syndrome
por: Joob, B., et al.
Publicado: (2020)

Guillain-Barre Syndrome, Neuroborreliosis, or Both
por: Owens, Joey, et al.
Publicado: (2020)

AZD-1222: Guillain-Barre syndrome
Publicado: (2021)

Mimics and Chameleons in Guillain-Barré Syndrome
por: ., Fadila, et al.
Publicado: (2021)

Autoantibody screening in Guillain–Barré syndrome
por: Lleixà, Cinta, et al.
Publicado: (2021)

BAMLANIVIMAB-INDUCED GUILLAIN-BARRÉ SYNDROME
por: PALAGUACHI, GLADYS, et al.
Publicado: (2021)

Neuroborreliosis Presenting as Guillain-Barré Syndrome
por: Farr, Jacob, et al.
Publicado: (2023)

Hepatitis E virus‐associated Guillain–Barre syndrome: Revision of the literature
por: Liu, Hang, et al.
Publicado: (2019)

Erythropoietin and autoimmune neuroinflammation: lessons from experimental autoimmune encephalomyelitis and experimental autoimmune neuritis
por: Shin, Taekyun, et al.
Publicado: (2012)

Analysis of the Pathogenesis of Experimental Autoimmune Optic Neuritis
por: Kezuka, Takeshi, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_qk8meotnvmhub1n54u1uuou99s